{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:59:04Z","timestamp":1790956744455,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"DOI":"10.1007\/s00508-026-02827-4","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:45:53Z","timestamp":1790955953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum cholinesterase as a\u00a0prognostic marker in respiratory critical illness: a\u00a0narrative review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5685-856X","authenticated-orcid":false,"given":"Andreas","family":"Fazekas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-7201","authenticated-orcid":false,"given":"Erwin","family":"Grasmuk-Siegl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7478-5205","authenticated-orcid":false,"given":"Daniel","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"10","key":"2827_CR1","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus\u00a0WA, Draper\u00a0EA, Wagner\u00a0DP, Zimmerman\u00a0JE. APACHE II: a\u00a0severity of disease classification system. Crit Care Med. 1985;13(10):818\u201329. PMID: 3928249.","journal-title":"Crit Care Med"},{"issue":"7","key":"2827_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent\u00a0JL, Moreno\u00a0R, Takala\u00a0J, Willatts\u00a0S, De Mendon\u00e7a\u00a0A, Bruining\u00a0H, et\u00a0al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. Intensive Care Med. 1996;22(7):707\u201310. https:\/\/doi.org\/10.1007\/BF01709751.","journal-title":"Intensive Care Med"},{"issue":"5","key":"2827_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim\u00a0WS, van der Eerden\u00a0MM, Laing\u00a0R, Boersma\u00a0WG, Karalus\u00a0N, Town\u00a0GI, et\u00a0al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377\u201382. https:\/\/doi.org\/10.1136\/thorax.58.5.377.","journal-title":"Thorax"},{"issue":"4","key":"2827_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine\u00a0MJ, Auble\u00a0TE, Yealy\u00a0DM, Hanusa\u00a0BH, Weissfeld\u00a0LA, Singer\u00a0DE, et\u00a0al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243\u201350. https:\/\/doi.org\/10.1056\/NEJM199701233360402.","journal-title":"N Engl J Med"},{"issue":"3","key":"2827_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000065054","volume":"11","author":"J Massouli\u00e9","year":"2002","unstructured":"Massouli\u00e9\u00a0J. The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals. 2002;11(3):130\u201343. https:\/\/doi.org\/10.1159\/000065054.","journal-title":"Neurosignals"},{"key":"2827_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","volume":"148","author":"O Lockridge","year":"2015","unstructured":"Lockridge\u00a0O. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther. 2015;148:34\u201346. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.011.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2827_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1046\/j.1432-1327.1999.00693.x","volume":"264","author":"D Grisaru","year":"1999","unstructured":"Grisaru\u00a0D, Sternfeld\u00a0M, Eldor\u00a0A, Glick\u00a0D, Soreq\u00a0H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem. 1999;264(3):672\u201386. PMID: 10491113.","journal-title":"Eur J Biochem"},{"issue":"6683","key":"2827_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/30741","volume":"393","author":"D Kaufer","year":"1998","unstructured":"Kaufer\u00a0D, Friedman\u00a0A, Seidman\u00a0S, Soreq\u00a0H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature. 1998;393(6683):373\u20137. https:\/\/doi.org\/10.1038\/30741. Corrigendum: Nature. 2016;531(7592):126. https:\/\/doi.org\/10.1038\/nature16180.","journal-title":"Nature"},{"key":"2827_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman\u00a0GL, Courtney\u00a0KD, Andres\u00a0V, Featherstone\u00a0RM. A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"2827_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139480","volume":"10","author":"J Jo\u0144ca","year":"2015","unstructured":"Jo\u0144ca\u00a0J, \u017buk\u00a0M, Was\u0105g\u00a0B, Janaszak-Jasiecka\u00a0A, Lewandowski K, Wielgomas\u00a0B, et\u00a0al. New insights into butyrylcholinesterase activity assay: serum dilution factor as a crucial parameter. PLoS One. 2015;10(10):e0139480. https:\/\/doi.org\/10.1371\/journal.pone.0139480.","journal-title":"PLoS One"},{"issue":"4","key":"2827_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1042\/bj0540695","volume":"54","author":"L Austin","year":"1953","unstructured":"Austin\u00a0L, Berry\u00a0WK. Two selective inhibitors of cholinesterase. Biochem J. 1953;54(4):695\u2013700. PMID: 13058976.","journal-title":"Biochem J"},{"issue":"1","key":"2827_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1042\/bj0530062","volume":"53","author":"WN Aldridge","year":"1953","unstructured":"Aldridge\u00a0WN. The differentiation of true and pseudo cholinesterase by organophosphorus compounds. Biochem J. 1953;53(1):62\u20137. PMID: 13032034.","journal-title":"Biochem J"},{"key":"2827_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6038771","volume":"2024","author":"Z Chen","year":"2024","unstructured":"Chen\u00a0Z, Zha\u00a0L, Hu\u00a0B, Xu\u00a0B, Zuo\u00a0L, Yang\u00a0J, et\u00a0al. Use of the serum level of cholinesterase as a prognostic marker of nonfatal clinical outcomes in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease. Can Respir J. 2024;2024:6038771. https:\/\/doi.org\/10.1155\/2024\/6038771.","journal-title":"Can Respir J"},{"issue":"2","key":"2827_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/med.21745","volume":"41","author":"S Xing","year":"2021","unstructured":"Xing\u00a0S, Li\u00a0Q, Xiong\u00a0B, Chen\u00a0Y, Feng\u00a0F, Liu\u00a0W, Sun\u00a0H. Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer\u2019s disease, and fat metabolism. Med Res Rev. 2021;41(2):858\u2013901. https:\/\/doi.org\/10.1002\/med.21745.","journal-title":"Med Res Rev"},{"issue":"3","key":"2827_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1684\/abc.2016.1141","volume":"74","author":"H Delacour","year":"2016","unstructured":"Delacour\u00a0H, Dedome\u00a0E, Courcelle\u00a0S, Hary\u00a0B, Ceppa\u00a0F. Butyrylcholinesterase deficiency. Ann Biol Clin. 2016;74(3):279\u201385. https:\/\/doi.org\/10.1684\/abc.2016.1141.","journal-title":"Ann Biol Clin (Paris)"},{"key":"2827_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cbi.2019.05.007","volume":"307","author":"J Jasiecki","year":"2019","unstructured":"Jasiecki\u00a0J, \u017buk\u00a0M, Krawczy\u0144ska\u00a0N, Jo\u0144ca\u00a0J, Szczoczarz\u00a0A, Lewandowski\u00a0K, et\u00a0al. Haplotypes of butyrylcholinesterase K\u2011variant and their influence on the enzyme activity. Chem Biol Interact. 2019;307:154\u20137. https:\/\/doi.org\/10.1016\/j.cbi.2019.05.007.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"2827_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","volume":"4","author":"L Santarpia","year":"2013","unstructured":"Santarpia\u00a0L, Grandone\u00a0I, Contaldo\u00a0F, Pasanisi\u00a0F. Butyrylcholinesterase as a\u00a0prognostic marker: a\u00a0review of the literature. J\u00a0Cachexia Sarcopenia Muscle. 2013;4(1):31\u20139. https:\/\/doi.org\/10.1007\/s13539-012-0083-5.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2827_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/274607","volume":"2015","author":"AR Zivkovic","year":"2015","unstructured":"Zivkovic\u00a0AR, Schmidt\u00a0K, Sigl\u00a0A, Decker\u00a0SO, Brenner\u00a0T, Hofer\u00a0S. Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients. Mediators Inflamm. 2015;2015:274607. https:\/\/doi.org\/10.1155\/2015\/274607.","journal-title":"Mediators Inflamm"},{"issue":"6921","key":"2827_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang\u00a0H, Yu\u00a0M, Ochani\u00a0M, Amella\u00a0CA, Tanovic\u00a0M, Susarla\u00a0S, et\u00a0al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421(6921):384\u20138. https:\/\/doi.org\/10.1038\/nature01339.","journal-title":"Nature"},{"issue":"1","key":"2827_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/15412555.2023.2209178","volume":"20","author":"Z Chen","year":"2023","unstructured":"Chen\u00a0Z, Zha\u00a0L, Feng\u00a0G, An\u00a0Q, Shi\u00a0F, Xu\u00a0J, et\u00a0al. Prognostic value of serum cholinesterase levels for in-hospital mortality among patients with acute exacerbation of chronic obstructive pulmonary disease. COPD. 2023;20(1):178\u201385. https:\/\/doi.org\/10.1080\/15412555.2023.2209178.","journal-title":"COPD"},{"issue":"1","key":"2827_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s002280000259","volume":"57","author":"K Abou-Hatab","year":"2001","unstructured":"Abou-Hatab\u00a0K, Ganeshalingam\u00a0K, O\u2019Mahony\u00a0MS, Giurani\u00a0F, Patel\u00a0S, Woodhouse\u00a0K. The effect of community-acquired pneumonia on plasma esterases in older people. Eur J Clin Pharmacol. 2001;57(1):55\u201360. https:\/\/doi.org\/10.1007\/s002280000259.","journal-title":"Eur J Clin Pharmacol"},{"key":"2827_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-015-0143-7","volume":"15","author":"N Akuzawa","year":"2015","unstructured":"Akuzawa\u00a0N, Naito\u00a0H. Nutritional parameters affecting severity of pneumonia and length of hospital stay in patients with pneumococcal pneumonia: a\u00a0retrospective cross-sectional study. BMC Pulm Med. 2015;15:149. https:\/\/doi.org\/10.1186\/s12890-015-0143-7.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"2827_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106672","volume":"92","author":"T Wybranowski","year":"2026","unstructured":"Wybranowski\u00a0T, Napi\u00f3rkowska-Mastalerz\u00a0M, Dybowska\u00a0K, \u017bekanowska\u00a0E, Kruszewski\u00a0S, Przybylski\u00a0G. Butyrylcholinesterase as an overlooked prognostic biomarker of 100-day mortality in non-COVID CAP. J\u00a0Infect. 2026;92(2):106672. https:\/\/doi.org\/10.1016\/j.jinf.2025.106672.","journal-title":"J Infect"},{"issue":"1","key":"2827_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4266\/acc.2021.00129","volume":"37","author":"M Bahloul","year":"2022","unstructured":"Bahloul\u00a0M, Kharrat\u00a0S, Chtara\u00a0K, Hafdhi\u00a0M, Turki\u00a0O, Baccouche\u00a0N, et\u00a0al. Clinical characteristics and outcomes of critically ill COVID-19 patients in Sfax, Tunisia. Acute Crit Care. 2022;37(1):84\u201393. https:\/\/doi.org\/10.4266\/acc.2021.00129.","journal-title":"Acute Crit Care"},{"issue":"3","key":"2827_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4269\/ajtmh.21-0934","volume":"107","author":"M Bahloul","year":"2022","unstructured":"Bahloul\u00a0M, Kharrat\u00a0S, Makni\u00a0S, Baccouche\u00a0N, Ammar\u00a0R, Eleuch\u00a0A, et\u00a0al. Prognostic value of serum cholinesterase activity in severe SARS-CoV-2-infected patients requiring intensive care unit admission. Am J Trop Med Hyg. 2022;107(3):534\u20139. https:\/\/doi.org\/10.4269\/ajtmh.21-0934.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2827_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07017-2","volume":"15","author":"T Fazeka\u0161","year":"2025","unstructured":"Fazeka\u0161\u00a0T, Kov\u00e1\u010dik\u00a0L, Motahari Rad\u00a0M, Gabald\u00f3 Barrios\u00a0X, Iftimie\u00a0SM, Camps\u00a0J, Hrabovsk\u00e1\u00a0A. Serum butyrylcholinesterase activity as a predictor of severity and mortality in COVID-19 patients. Sci Rep. 2025;15(1):23437. https:\/\/doi.org\/10.1038\/s41598-025-07017-2.","journal-title":"Sci Rep"},{"key":"2827_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.940533","volume":"9","author":"H Sipahioglu","year":"2022","unstructured":"Sipahioglu\u00a0H, Esmaoglu\u00a0A, Kiris\u00a0A, Dursun\u00a0ZB, Kuzuguden\u00a0S, Cavus\u00a0MA, et\u00a0al. Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia? Front Med. 2022;9:940533. https:\/\/doi.org\/10.3389\/fmed.2022.940533.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"2827_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jinf.2020.08.021","volume":"82","author":"K Nakajima","year":"2021","unstructured":"Nakajima\u00a0K, Abe\u00a0T, Saji\u00a0R, Ogawa\u00a0F, Taniguchi\u00a0H, Yamaguchi\u00a0K, et\u00a0al. Serum cholinesterase associated with COVID-19 pneumonia severity and mortality. J\u00a0Infect. 2021;82(2):321\u20133. https:\/\/doi.org\/10.1016\/j.jinf.2020.08.021.","journal-title":"J Infect"},{"issue":"9","key":"2827_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092150","volume":"12","author":"F Espeter","year":"2022","unstructured":"Espeter\u00a0F, K\u00fcnne\u00a0D, Garczarek\u00a0L, Kuhlmann\u00a0H, Skarabis\u00a0A, Zivkovic\u00a0AR, et\u00a0al. Critically ill COVID-19 patients show reduced point of care-measured butyrylcholinesterase activity\u2014a prospective, monocentric observational study. Diagnostics. 2022;12(9):2150. https:\/\/doi.org\/10.3390\/diagnostics12092150.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"2827_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3760\/cma.j.issn.2095-4352.2016.01.008","volume":"28","author":"X Mo","year":"2016","unstructured":"Mo\u00a0X, Tang\u00a0H, Zeng\u00a0L, Lu\u00a0H, Guo\u00a0L, Ma\u00a0Z. [The value of determination of serum cholinesterase levels in judgment of severity and prognosis in patients with severe pneumonia]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016;28(1):38\u201343. https:\/\/doi.org\/10.3760\/cma.j.issn.2095-4352.2016.01.008. Chinese.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2827_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1175089","volume":"10","author":"J Liu","year":"2023","unstructured":"Liu\u00a0J, Shao\u00a0T, Chen\u00a0H, Ma\u00a0C, Lu\u00a0X, Yang\u00a0X, et\u00a0al. Serum cholinesterase as a new nutritional indicator for predicting weaning failure in patients. Front Med. 2023;10:1175089. https:\/\/doi.org\/10.3389\/fmed.2023.1175089.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"2827_CR32","first-page":"80","volume":"30","author":"Y Yang","year":"2024","unstructured":"Yang\u00a0Y, Wang\u00a0Q, Yu\u00a0Z. Prognostic factors of severe pneumonia in adult patients: a\u00a0systematic review. Altern Ther Health Med. 2024;30(5):80\u20139. PMID: 37971449.","journal-title":"Altern Ther Health Med"},{"issue":"11","key":"2827_CR33","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00296-009-0857-z","volume":"29","author":"Y Aoki","year":"2009","unstructured":"Aoki\u00a0Y, Iwamoto\u00a0M, Kamata\u00a0Y, Nagashima\u00a0T, Yoshio\u00a0T, Okazaki\u00a0H, et\u00a0al. Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases. Rheumatol Int. 2009;29(11):1327\u201330. https:\/\/doi.org\/10.1007\/s00296-009-0857-z.","journal-title":"Rheumatol Int"},{"issue":"8","key":"2827_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203128","volume":"13","author":"ZL Peng","year":"2018","unstructured":"Peng\u00a0ZL, Huang\u00a0LW, Yin\u00a0J, Zhang\u00a0KN, Xiao\u00a0K, Qing\u00a0GZ. Association between early serum cholinesterase activity and 30-day mortality in sepsis\u20113 patients: a retrospective cohort study. PLoS One. 2018;13(8):e0203128. https:\/\/doi.org\/10.1371\/journal.pone.0203128.","journal-title":"PLoS One"},{"issue":"3","key":"2827_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S1665-2681(19)30932-9","volume":"11","author":"N Lamp\u00f3n","year":"2012","unstructured":"Lamp\u00f3n\u00a0N, Hermida-Cadahia\u00a0EF, Riveiro\u00a0A, Tutor\u00a0JC. Association between butyrylcholinesterase activity and low-grade systemic inflammation. Ann Hepatol. 2012;11(3):356\u201363. PMID: 22481455.","journal-title":"Ann Hepatol"},{"key":"2827_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcrc.2019.02.004","volume":"51","author":"R Takegawa","year":"2019","unstructured":"Takegawa\u00a0R, Kabata\u00a0D, Shimizu\u00a0K, Hisano\u00a0S, Ogura\u00a0H, Shintani\u00a0A, Shimazu\u00a0T. Serum albumin as a\u00a0risk factor for death in patients with prolonged sepsis: an observational study. J\u00a0Crit Care. 2019;51:139\u201344. https:\/\/doi.org\/10.1016\/j.jcrc.2019.02.004.","journal-title":"J Crit Care"},{"key":"2827_CR37","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S604454","volume":"21","author":"L Xiao","year":"2026","unstructured":"Xiao\u00a0L, Qin\u00a0Y, Wen\u00a0Y, Guo\u00a0X, Wang\u00a0Y, Wang\u00a0Y, Wang\u00a0Z. Explainable machine learning model based on routine admission laboratory tests for predicting new-onset hypoalbuminemia in hospitalized older patients with acute exacerbation of COPD. Clin Interv Aging. 2026;21:604454. https:\/\/doi.org\/10.2147\/CIA.S604454.","journal-title":"Clin Interv Aging"},{"issue":"6","key":"2827_CR38","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/jcsm.12463","volume":"10","author":"HY Kwan","year":"2019","unstructured":"Kwan\u00a0HY, Maddocks\u00a0M, Nolan\u00a0CM, Jones\u00a0SE, Patel\u00a0S, Barker\u00a0RE, et\u00a0al. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study. J\u00a0Cachexia Sarcopenia Muscle. 2019;10(6):1330\u20138. https:\/\/doi.org\/10.1002\/jcsm.12463.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2827_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.809449","volume":"9","author":"C Yue","year":"2022","unstructured":"Yue\u00a0C, Zhang\u00a0C, Ying\u00a0C, Jiang\u00a0H. Reduced serum cholinesterase is an independent risk factor for all-cause mortality in the pediatric intensive care unit. Front Nutr. 2022;9:809449. https:\/\/doi.org\/10.3389\/fnut.2022.809449.","journal-title":"Front Nutr"},{"key":"2827_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110557","volume":"381","author":"L Markuskova","year":"2023","unstructured":"Markuskova\u00a0L, Javorova Rihova\u00a0Z, Fazekas\u00a0T, Martinkovicova\u00a0A, Havrisko\u00a0M, Dingova\u00a0D, et\u00a0al. Serum butyrylcholinesterase as a marker of COVID-19 mortality: results of the monocentric prospective observational study. Chem Biol Interact. 2023;381:110557. https:\/\/doi.org\/10.1016\/j.cbi.2023.110557.","journal-title":"Chem Biol Interact"},{"key":"2827_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/IJGM.S102819","volume":"9","author":"DG Levitt","year":"2016","unstructured":"Levitt\u00a0DG, Levitt\u00a0MD. Human serum albumin homeostasis: a\u00a0new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229\u201355. https:\/\/doi.org\/10.2147\/IJGM.S102819.","journal-title":"Int J Gen Med"},{"issue":"1","key":"2827_CR42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s13054-016-1536-6","volume":"20","author":"A Kom\u00e1romi","year":"2016","unstructured":"Kom\u00e1romi\u00a0A, Estenberg\u00a0U, Hammarqvist\u00a0F, Rooyackers\u00a0O, Wernerman\u00a0J, Norberg \u00c5. Simultaneous assessment of the synthesis rate and transcapillary escape rate of albumin in inflammation and surgery. Crit Care. 2016;20(1):370. https:\/\/doi.org\/10.1186\/s13054-016-1536-6.","journal-title":"Crit Care"},{"issue":"3","key":"2827_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.33549\/physiolres.935558","volume":"74","author":"T Hodbod","year":"2025","unstructured":"Hodbod\u00a0T, Szmicsekova\u00a0K, Cinakova\u00a0A, Stefikova\u00a0K, Krivosikova\u00a0Z, Kralova\u00a0E, et\u00a0al. Altered plasma butyrylcholinesterase activity in streptozotocin-induced diabetic hypertensive rats does not reflect impaired liver function. Physiol Res. 2025;74(3):471\u201380. PMID: 40698664.","journal-title":"Physiol Res"},{"issue":"1","key":"2827_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13054-015-0741-z","volume":"19","author":"C Chelazzi","year":"2015","unstructured":"Chelazzi\u00a0C, Villa\u00a0G, Mancinelli\u00a0P, De Gaudio\u00a0AR, Adembri\u00a0C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care. 2015;19(1):26. https:\/\/doi.org\/10.1186\/s13054-015-0741-z.","journal-title":"Crit Care"},{"issue":"9","key":"2827_CR45","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1515\/cclm-2025-0240","volume":"63","author":"ED Akbulut","year":"2025","unstructured":"Akbulut\u00a0ED, Ercan\u00a0M. Biological variation of serum cholinesterase activity in healthy subjects. Clin Chem Lab Med. 2025;63(9):1847\u201354. https:\/\/doi.org\/10.1515\/cclm-2025-0240.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2827_CR46","first-page":"313","volume":"78","author":"FK Soliday","year":"2010","unstructured":"Soliday\u00a0FK, Conley\u00a0YP, Henker\u00a0R. Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences. AANA J. 2010;78(4):313\u201320. PMID: 20879632.","journal-title":"AANA J"},{"issue":"1","key":"2827_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins\u00a0GS, Reitsma\u00a0JB, Altman\u00a0DG, Moons\u00a0KGM. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(1):55\u201363. https:\/\/doi.org\/10.7326\/M14-0697.","journal-title":"Ann Intern Med"},{"issue":"5","key":"2827_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001216","volume":"9","author":"DG Altman","year":"2012","unstructured":"Altman\u00a0DG, McShane\u00a0LM, Sauerbrei\u00a0W, Taube\u00a0SE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration. PLoS Med. 2012;9(5):e1001216. https:\/\/doi.org\/10.1371\/journal.pmed.1001216.","journal-title":"PLoS Med"},{"key":"2827_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1942193","volume":"2018","author":"AR Zivkovic","year":"2018","unstructured":"Zivkovic\u00a0AR, Decker\u00a0SO, Zirnstein\u00a0AC, Sigl\u00a0A, Schmidt\u00a0K, Weigand\u00a0MA, et\u00a0al. A sustained reduction in serum cholinesterase enzyme activity predicts patient outcome following sepsis. Mediators Inflamm. 2018;2018:1942193. https:\/\/doi.org\/10.1155\/2018\/1942193.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"2827_CR50","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5114\/ait.2021.108624","volume":"53","author":"M Bahloul","year":"2021","unstructured":"Bahloul\u00a0M, Bradii\u00a0S, Turki\u00a0M, Bouchaala\u00a0K, Ben Hamida\u00a0C, Chelly\u00a0H, Ayedi\u00a0F, Bouaziz\u00a0M. The value of sepsis biomarkers and their kinetics in the prognosis of septic shock due to bacterial infections. Anaesthesiol Intensive Ther. 2021;53(4):312\u20138. https:\/\/doi.org\/10.5114\/ait.2021.108624.","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"8","key":"2827_CR51","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1515\/CCLM.2008.220","volume":"46","author":"T Gamsj\u00e4ger","year":"2008","unstructured":"Gamsj\u00e4ger\u00a0T, Brenner\u00a0L, Sitzwohl\u00a0C, Weinstabl\u00a0C. Half-lives of albumin and cholinesterase in critically ill patients. Clin Chem Lab Med. 2008;46(8):1140\u20132. https:\/\/doi.org\/10.1515\/CCLM.2008.220.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2827_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30756-z","volume":"13","author":"Y Jacob","year":"2023","unstructured":"Jacob\u00a0Y, Schneider\u00a0B, Spies\u00a0C, Heinrich\u00a0M, von Haefen\u00a0C, Kho\u00a0W, Pohrt\u00a0A, M\u00fcller\u00a0A. Dexmedetomidine blocks cholinergic dysregulation in delirium pathogenesis in patients with major surgery: a\u00a0secondary analysis. Sci Rep. 2023;13(1):3971. https:\/\/doi.org\/10.1038\/s41598-023-30756-z.","journal-title":"Sci Rep"},{"key":"2827_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1459268","volume":"11","author":"TS Zajonz","year":"2024","unstructured":"Zajonz\u00a0TS, Edinger\u00a0F, Markmann\u00a0M, Gr\u00e4b\u00a0K, Sander\u00a0M, Kunzemann\u00a0C, Koch\u00a0C, Schneck\u00a0E. Optimization of the cardiac delirium index by including age, decrease in butyrylcholinesterase activity, preoperative HbA1c, and postoperative hemoglobin levels: results of a secondary analysis of a prospective observational study. Front Cardiovasc Med. 2024;11:1459268. https:\/\/doi.org\/10.3389\/fcvm.2024.1459268.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"2827_CR54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco\u00a0AC, Lillie\u00a0E, Zarin\u00a0W, O\u2019Brien\u00a0KK, Colquhoun\u00a0H, Levac\u00a0D, et\u00a0al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"2827_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5012874","volume":"2019","author":"C Chiarla","year":"2019","unstructured":"Chiarla\u00a0C, Giovannini\u00a0I. Comment on \u201cA\u00a0sustained reduction in serum cholinesterase enzyme activity predicts patient outcome following sepsis\u201d. Mediators Inflamm. 2019;2019:5012874. https:\/\/doi.org\/10.1155\/2019\/5012874.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2827_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1751143719900100","volume":"22","author":"RD Savio","year":"2021","unstructured":"Savio\u00a0RD, Parasuraman\u00a0R, Lovesly\u00a0D, Shankar\u00a0B, Ranganathan\u00a0L, Ramakrishnan\u00a0N, et\u00a0al. Feasibility, tolerance and effectiveness of enteral feeding in critically ill patients in prone position. J\u00a0Intensive Care Soc. 2021;22(1):41\u20136. https:\/\/doi.org\/10.1177\/1751143719900100.","journal-title":"J Intensive Care Soc"},{"issue":"5","key":"2827_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70046","volume":"45","author":"M Heni","year":"2025","unstructured":"Heni\u00a0M, Hummel\u00a0J, Fritsche\u00a0L, Wagner\u00a0R, Relker\u00a0L, Machann\u00a0J, et\u00a0al. Elevated cholinesterase activity and the metabolic syndrome \u2014 dissecting fatty liver, insulin resistance and dysglycaemia. Liver Int. 2025;45(5):e70046. https:\/\/doi.org\/10.1111\/liv.70046.","journal-title":"Liver Int"},{"issue":"5","key":"2827_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0952-8180(02)00382-3","volume":"14","author":"B Naik","year":"2002","unstructured":"Naik\u00a0B, Hirshhorn\u00a0S, Dharnidharka\u00a0VR. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis. J\u00a0Clin Anesth. 2002;14(5):381\u20134. https:\/\/doi.org\/10.1016\/s0952-8180(02)00382-3.","journal-title":"J Clin Anesth"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-026-02827-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:45:55Z","timestamp":1790955955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-026-02827-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":58,"alternative-id":["2827"],"URL":"https:\/\/doi.org\/10.1007\/s00508-026-02827-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. As a\u00a0narrative review of previously published data, approval by an ethics committee was not applicable.","order":1,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.\u00a0Fazekas, E.\u00a0Grasmuk-Siegl and D.\u00a0Moser declare that they have no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}